Abstract

PurposeTo describe the diffusion-weighted imaging (DWI) appearance of gestational trophoblastic disease (GTD) and to determine its apparent diffusion coefficient (ADC) values. To evaluate the feasibility of DWI to predict progression of hydatidiform mole (HM) to persistent disease. MethodsDuring a period of 6 months, women with preliminary diagnosis of GTD, based on ultrasound and ßhCG levels, underwent 1.5T MRI (T2 high-resolution and DWI; b values 50, 400, 800; sagittal and perpendicular to the endometrium; and T1, T2 Turbo Spin Echo [TSE] axial images). Patients were followed for 6–12 months to monitor progression to persistent form of the disease. ADC values and image characteristics were compared between HM and persistent neoplasia and between GTD and non-molar pregnancy using Mann–Whitney U and Fisher’s exact tests, respectively. ResultsAmong the 23 studied patients, 19 (83%) were classified as molar and 4 (17%) as non-molar, based on pathology reports. After 6–12 months of follow-up, 5 (26%) cases progressed to persistent disease and 14 (74%) cases were benign HM. There was no significant difference between ADC values for HM (1.93±0.33×10−3mm2/s) and persistent neoplasia (2.03±0.28×10−3mm2/s) (P=0.69). The ADC of non-molar pregnancies was (0.96±0.46×10−3mm2/s), which was significantly different from GTD (1.96 ±0.32×10−3mm2/s) (P=0.001). Heterogeneous snowstorm appearance, focal intratumoral hemorrhage, myometrial contraction, and prominent myometrial vascularity were more common in GTD compared to non-molar pregnancy (P<0.05). ConclusionHeterogeneous snowstorm appearance, focal intratumoral hemorrhage, myometrial contraction, and prominent myometrial vascularity are among the imaging characteristics of GTD. We cannot use ADC values to predict progression to persistent disease.

Highlights

  • Gestational trophoblastic diseases (GTD) include a spectrum of pregnancy-related diseases caused by abnormal proliferation of the placenta

  • We aimed to describe the diffusion-weighted imaging (DWI) appearance of GTD and to measure apparent diffusion coefficient (ADC) values of the tumor

  • After 6–12 months of follow-up with the measurement of serum ␤hCG levels, 5 (26%) of the 19 patients progressed to a persistent form of disease and 14 (74%) patients showed decreasing ␤hCG levels and were classified as having benign hydatidiform mole (HM)

Read more

Summary

Introduction

Gestational trophoblastic diseases (GTD) include a spectrum of pregnancy-related diseases caused by abnormal proliferation of the placenta. The spectrum includes both benign hydatidiform mole (HM) and invasive/malignant gestational trophoblastic neoplasia (GTN). GTNs are characterized by a propensity for local invasion and distant metastases. These neoplasms usually follow a molar pregnancy, but can occur after a normal pregnancy or abortion [1,2]. The incidence of GTD varies widely in different geographical regions. In South East Asia and Japan, the incidence is as high as 2 per 1000 pregnancies, and 8 per 1000 pregnancies in Thailand. Epidemiological studies in Iran have reported an incidence of 5.4 per 1000 pregnancies for HM [1,3,4]

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call